Atlas Trials

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

Clinical trial NCT06630273 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06630273
Sponsor
Canadian Cancer Trials Group
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Carcinoma
Start date
2026-07-31
Primary completion
2027-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.